Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 3 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.84)
Consensus Price Target: $116.93 (3.32% downside)

Current Analysts' Coverage Summary for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/27/2015Deutsche BankBoost Price TargetBuy$90.00 -> $140.00ViewTweet This Rating  Share This Rating on StockTwits
3/13/2015Jefferies GroupBoost Price TargetBuy$125.00 -> $135.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2015WedbushReiterated RatingNeutral$104.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
2/26/2015Canaccord GenuitySet Price TargetBuy$115.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2015JPMorgan Chase & Co.Boost Price TargetOverweight$110.00 -> $120.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2015Citigroup Inc.Reiterated RatingBuy$94.00 -> $133.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2015Leerink SwannBoost Price TargetOutperform$107.00 -> $136.00ViewTweet This Rating  Share This Rating on StockTwits
2/23/2015ZacksUpgradeNeutral -> Outperform$129.00ViewTweet This Rating  Share This Rating on StockTwits
2/9/2015Bank of AmericaInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/29/2015Evercore ISIInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/23/2015Robert W. BairdBoost Price TargetOutperform$95.00 -> $120.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2015NomuraReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
1/12/2015RBC CapitalSet Price TargetBuy$110.00ViewTweet This Rating  Share This Rating on StockTwits
11/10/2014Goldman SachsUpgradeNeutral -> Buy$78.00 -> $104.00ViewTweet This Rating  Share This Rating on StockTwits
11/3/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/27/2014Credit Suisse Group AGReiterated RatingOutperform$74.00 -> $75.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2014SunTrustInitiated CoverageBuy$100.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/27/2014Cowen and CompanyBoost Price Target$85.00 -> $95.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014BarclaysBoost Price TargetEqual Weight$73.00 -> $76.00ViewTweet This Rating  Share This Rating on StockTwits
11/29/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/27/2013Piper JaffrayReiterated RatingOverweightViewTweet This Rating  Share This Rating on StockTwits
10/22/2013HSBCBoost Price TargetOverweight$46.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013William BlairReiterated RatingHold$88.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Stifel NicolausDowngradeBuy -> Hold$70.00ViewTweet This Rating  Share This Rating on StockTwits
4/18/2013Lazard Capital MarketsBoost Price TargetBuy$71.00 -> $77.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/1/2013 forward)